Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,912
Study of ON 123300 in Patients With Advanced Cancer
for
Solid Tumors, Adult
Location: Dallas TX, Greenville SC, Grand Rapids MI
Sponsor: Traws Pharma, Inc.
Sex: All
Age: 18+
Code: NCT04739293
Phase1, Recruiting
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
for
Focal Epilepsy
Location: Dallas TX, San Antonio TX, Little Rock AR, St Louis MO,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 70+
Code: NCT06132893
Phase2, Phase3, Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Plano TX, Austin TX, Oklahoma City OK, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 0+
Code: NCT06480383
Phase2, Recruiting
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
for
Glioblastoma Multiforme
Location: Dallas TX, Chicago IL, Detroit MI, Durham NC,
Sponsor: Novacea
Sex: All
Age: 18+
Code: NCT00394628
Phase1, Phase2, Recruiting
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
for
LCA5
Location: Dallas TX, Philadelphia PA
Sponsor: Opus Genetics, Inc
Sex: All
Age: 4+
Code: NCT05616793
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Dallas TX, McKinney TX, Edmond OK, Kansas City KS,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase2, Recruiting
New
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications